04/12/2006 Filing of a marketing authorization application for Sinerem
At the end of November, Guerbet filed a marketing authorization application with the EMEA ....
[more]30/10/2006 Contrast-Induced Nephropathy
no difference between low-osmolarity and iso-osmolar contrast agents
[more]14/09/2006 Innovation by Guerbet
Xenetix in Scanbag. Continuing with its strategy of innovation, Guerbet is launching...
[more]